Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes.

Cardiovascular Diabetology
Bin FengNannan Zhang

Abstract

The prevalence of peripheral artery disease (PAD) is obviously increased in patients with diabetes. Existing evidence shows that cysteine-rich angiogenic inducer 61 (Cyr61), a 40-kD secreted protein, plays important roles in regulating cellular physiological processes. Recent studies have demonstrated a significant correlation between serum Cyr61 and atherosclerosis. However, the relationship between Cyr61 levels and PAD in patients with type 2 diabetes (T2DM) remains obscure. Data from a total of 306 subjects with T2DM were cross-sectionally analysed. The extent of PAD was determined by using the Fontaine classification, which defines four stages. We measured serum Cyr61 concentrations by ELISA in subjects with and without PAD at Fontaine's stage II, III, or IV. Logistic regression models were used to examine the independent association of Cyr61 with PAD. Out of the 306 subjects enrolled, 150 were free from PAD, while 156 had clinically significant PAD. In subjects with PAD, the prevalences of Fontaine classification stages II, III and IV were 48.7%, 32.1%, and 19.2%, respectively. Patients with more advanced PAD had significantly higher Cyr61 (P for trend < 0.001). The prevalence of PAD on the basis of severity increased with...Continue Reading

References

Apr 5, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Hironobu MatsumaeMakoto Tanaka
Aug 2, 2011·Cellular and Molecular Life Sciences : CMLS·Lester F Lau
Jun 10, 2014·Nature Communications·Rabea HinkelChristian Kupatt
May 20, 2015·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Masatoshi KomatsuHiroyuki Kato
May 27, 2017·Ocular Immunology and Inflammation·Young Jun WooJin Sook Yoon
Aug 8, 2017·Nanomedicine : Nanotechnology, Biology, and Medicine·Yuyu YaoNaifeng Liu
Mar 16, 2018·Journal of the American College of Cardiology·Sonia S AnandSalim Yusuf
Jun 23, 2018·Clinical Science·Glaucylara Reis Geovanini, Peter Libby
Oct 26, 2018·Cardiovascular Diabetology·Mathilde NativelKamel Mohammedi
Jan 13, 2019·Cardiovascular Diabetology·Federico BiscettiAndrea Flex
Jun 7, 2019·Cardiovascular Diabetology·Federico BiscettiAndrea Flex
Jun 23, 2019·Heart and Vessels·Bernhard ZierfussGerit-Holger Schernthaner
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Aug 31, 2021·Frontiers in Cardiovascular Medicine·Haicheng LiYanming Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
percutaneous transluminal coronary angioplasty The
ELISA

Software Mentioned

Prism
GraphPad
PASS
GraphPad Prism

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.